Muscular disease

2 papers

Trial sponsors

Arcellx
Company1 trialPhase 130 people
Boston Medical Center
1 trialPhase 4209 people
Oslo University Hospital
1 trialPhase 453 people
Johns Hopkins University
1 trialPhase 119 people

Latest

4 in 12 months

ADA Scientific Sessions 2026 Abstract5 Jun

Evaluation of Sarcopenia in Adults over 50 Years with Type 1 Diabetes: Single-Centre Observational Study

Cross-sectional study of 73 peopleType 1 diabetes

Biochemical Pharmacology2 Mar

The cGAS-STING signaling pathway: A central regulator and novel therapeutic target in skeletal muscle pathophysiology

ReviewcGAS–STING signalling

FASEB Journal23 Feb

Senescent-Like Myofibers Contribute to Anti-Regenerative Cytokine Signaling in Duchenne Muscular Dystrophy

Experiments in ratsCellular senescence

Gut Microbes27 Dec

The role of gut microbiome in aging-associated diseases: where do we stand now and how technology will transform the future

ReviewMicrobiome composition

Journal of Advanced Research6 Jul

Aging induces sarcopenia by disrupting the crosstalk between the skeletal muscle microenvironment and myofibers

ReviewMechanisms

FASEB Journal6 Mar

SPP1 macrophages across diseases: A call for reclassification?

ReviewMechanisms